The expert blog 6770

Every few months a new claim cycles through health podcasts and social media: if you fast for 72 hours, your body will “reset,” your immune system will “rebuild,” and you will “regenerate” new cells as if you had a new lease on life. There is a grain of truth buried inside that promise, but it is surrounded by a lot of wishful thinking and marketing language. As a physician who works with metabolic health and regenerative medicine, I see both sides: the genuinely exciting science and the very real risks when people treat early data as settled fact. This article walks through what we actually know about 72 hour fasting, autophagy, stem cells, and “regeneration,” and how that intersects with the broader field of regenerative medicine. I will also address practical questions patients often ask me, including cost, insurance, discomfort, and who is and is not a good candidate. What “cell regeneration” really means The phrase “cell regeneration” gets used loosely. In biology and in clinical practice, it usually means one of three things. First, routine cellular turnover. Your gut lining renews roughly every few days, your skin over several weeks, and your red blood cells every 3 months or so. This is normal physiology, not a special hack. Second, repair after injury. When your liver is damaged by alcohol or toxins, it can regenerate large portions of itself if the injury is not too advanced. Skeletal muscle, bone, and even some heart tissue can remodel after damage, although not perfectly. Third, true regenerative processes. In research laboratories, scientists talk about regeneration at several levels. A simple textbook breakdown of the 4 types of regeneration includes: Epimorphosis, where cells at the injury site de-differentiate and form a blastema that regrows a lost structure, as in salamander limb regrowth. Morphallaxis, where remaining tissue reorganizes to form a smaller but complete organism, as in some hydra species. Compensatory regeneration, where remaining cells divide to restore function without forming a blastema, as seen in mammalian liver regeneration. Cellular regeneration, where specific cell populations, often stem or progenitor cells, repopulate damaged tissue. Humans have limited epimorphic ability compared to animals like salamanders, but we do use compensatory and cellular regeneration constantly. The excitement around fasting comes from its potential to push the body toward more efficient cellular cleanup and renewal, especially through autophagy and stem cell activation. What happens in a 72 hour fast In my practice, I rarely recommend an unsupervised water-only 72 hour fast, especially for first timers. But to understand why people are drawn to it, you need a clear view of the physiology. The human body stores energy first as glycogen in liver and muscle, and second as fat. Short fasts mostly deplete glycogen. By around 24 hours without calories, most people have burned through a substantial portion of liver glycogen and are relying more heavily on fat stores, producing ketones as an alternative fuel. Between roughly 24 and 72 hours, several important shifts occur: Glucose and insulin fall. Lower insulin means less anabolic signaling and more catabolic cleanup. For those with insulin resistance, this period can feel surprisingly stable once they get over the first day. Ketones rise. Beta-hydroxybutyrate, a primary ketone, increases and serves as fuel for the brain and muscles. Many people report better mental clarity and reduced hunger once they are fully in ketosis. Autophagy becomes more active. Autophagy is an intracellular housekeeping process where cells break down damaged proteins and organelles. Nutrient deprivation is one of the stronger triggers. Most of the detailed autophagy data comes from animal and cell models, but indirect markers in humans suggest that fasting and significant caloric restriction increase autophagic activity. Immune cell dynamics shift. This is where the “immune regeneration” headlines come from. In mouse studies, repeated cycles of prolonged fasting have been shown to reduce circulating white blood cells, then stimulate hematopoietic stem cells to generate new ones during refeeding. It is a logical, energy-efficient strategy: during scarcity, the body prunes older or less efficient immune cells, then repopulates when food returns. Hormones adjust. Growth hormone rises significantly in many people during longer fasts, which conserves muscle mass and supports lipolysis. Thyroid hormone conversion can shift, sometimes lowering triiodothyronine (T3) as the body conserves energy. So is the body “regenerating” during a 72 hour fast? Parts of it, in a limited and context-dependent way: more autophagy, some degree of immune cell turnover, and a metabolic environment that tends to favor cleanup over growth. What we do not have is strong human evidence that a single 72 hour fast “resets” your immune system or broadly regenerates organs in a way that would translate into dramatic long term health improvements on its own. Human data: what is known, what is not Most of the eye catching claims Regenerative Medicine Doctor Scottsdale about prolonged fasting and regeneration trace back to work by Valter Longo, PhD, and colleagues. In mice, cycles of prolonged fasting led to: Reductions in IGF-1 and other growth signals associated with aging Increased autophagy Enhanced hematopoietic stem cell driven regeneration of white blood cells after refeeding Benefits in models of autoimmunity and chemotherapy toxicity In humans, the data set is smaller and more nuanced: Fasting mimicking diets. Instead of strict water fasting, Longo’s group tested a 5 day very low calorie, low protein “fasting mimicking diet.” In small trials, participants saw reductions in IGF-1, blood pressure, and trunk fat, and favorable changes in certain inflammatory markers. There were hints of immune cell profile shifts, but not the dramatic “wipe and replace” seen in mice. Shorter fasts. Intermittent fasting and time restricted eating have more human data, especially for metabolic benefits: improved insulin sensitivity, weight loss, and possibly better blood pressure and lipids. These protocols rarely reach the 72 hour mark. True 72 hour water fasts. Here, human data is mostly from small experimental studies or observational reports, often with fewer than a few dozen participants. Outcomes like weight loss, ketone production, blood pressure, and subjective well being improve in many people. Markers of autophagy in humans are harder to measure directly, so much of what we infer comes from known physiology and animal data. As a clinician, I interpret the current state like this: a 72 hour fast probably increases autophagy meaningfully and may nudge certain stem cell populations to be more active during refeeding. It is very unlikely to regenerate organs in any dramatic way, and certainly not on the level of what we attempt with regenerative medicine procedures like stem cell injections or tissue engineering. Does fasting for 72 hours regenerate cells? The honest answer is: it depends what you mean by “regenerate,” but for most people the effect is modest, localized, and heavily dependent on what you do afterward. Here is a pragmatic breakdown: Cellular cleanup is very likely. Autophagy and related processes help cells remove damaged proteins, misfolded structures, and old mitochondria. A sustained period of nutrient deprivation is one of the better triggers we know. This cleanup is a key part of healthy cellular renewal. Some stem cell activation is plausible. In animal studies, hematopoietic and intestinal stem cells respond strongly to fasting and refeeding cycles. In humans, we suspect similar patterns, but do not have large scale, robust data. If stem cells are stimulated, the effect will be most evident in fast turnover tissues like blood and gut. Tissue level regeneration is limited. You are not regrowing cartilage or reversing a long standing tendon tear with a weekend fast. Chronic joint or spine damage, for instance, usually requires mechanical unloading, targeted rehab, and sometimes regenerative injections to see structural improvement. The benefit is cumulative. If you pair periodic fasting with resistance training, nutritional adequacy on eating days, sleep, and management of chronic diseases, you are likely to see significantly better function and longevity over time. A single isolated 72 hour fast is more like a metabolic stress test than a magic reset. So yes, fasting for 72 hours probably supports certain regenerative processes at the cellular level, especially cleanup and turnover in rapidly renewing tissues. No, it is not a substitute for comprehensive care, nor is it a guarantee of long term benefits. When a 72 hour fast is a bad idea In clinic, I spend more time talking people out of unsupervised prolonged fasting than talking them into it. The risks are real, especially if you have underlying conditions, take medications, or have a history of disordered eating. Here is a concise list of people who should completely avoid a 72 hour water-only fast unless they are in a formal, medically supervised program: Regenerative Medicine Doctor Scottsdale Those with type 1 diabetes or advanced type 2 diabetes on insulin or sulfonylureas Pregnant or breastfeeding individuals Anyone with a history of eating disorders, especially anorexia or bulimia People who are underweight, frail, or have significant unintentional weight loss Patients with advanced heart, kidney, or liver disease There are other gray zones. People on blood pressure medication, those with a history of gout, and those on multiple psychiatric medications need a careful, individualized plan and close monitoring if they fast beyond 24 hours. Electrolyte disturbances, severe hypotension, and mood changes are all possible. If someone is curious about fasting, I usually start with 12 to 16 hour overnight fasts, then progress gradually. Jumping straight to 72 hours is like going from couch to ultra-marathon with no training. Where fasting and regenerative medicine intersect Regenerative medicine is a broad, sometimes overhyped field that aims to repair, replace, or restore damaged cells, tissues, or organs. Patients come in asking: What is a regenerative medicine doctor exactly, and how does that connect to something as simple as not eating for a few days? A regenerative medicine doctor is usually a physician trained in a core specialty such as orthopedics, physical medicine and rehabilitation, sports medicine, internal medicine, or sometimes neurology, who then develops focused expertise in treatments that harness the body’s own repair mechanisms. That can include platelet rich plasma (PRP) injections, autologous stem cell procedures (using your own cells), certain scaffold or matrix implants, and in some cases biologic drugs that influence tissue regeneration. The most effective regenerative programs I have seen combine procedural therapies with systemic strategies. Metabolic health, sleep, resistance training, and nutrition directly affect how well your tissues respond to PRP or stem cell injections. Fasting sits squarely in that systemic bucket. A metabolically flexible person who tolerates light fasting, maintains a healthy weight, and has good glycemic control heals more predictably after a regenerative procedure than someone with uncontrolled diabetes and chronic inflammation. So while fasting is not regenerative medicine in the procedural sense, it can influence the internal environment in which regenerative therapies operate. The biggest problems and disadvantages of regenerative medicine Patients often arrive with sky high expectations, in part because they have heard stories from athletes or celebrities. Joe Rogan, for instance, has spoken frequently about receiving stem cell treatment in Panama, specifically at the Stem Cell Institute in Panama City, for joint and back issues. Clinics like that operate in a relatively permissive regulatory environment, which allows them to use cell types and protocols that are not approved in the United States. This highlights several core problems in the field. To keep it concrete, here are five of the most important disadvantages and challenges in regenerative medicine today: Variable evidence quality. Some uses, like PRP for certain tendon injuries, have decent randomized trial data. Others rely on case series, registry data, or marketing claims with very little rigorous backing. Regulatory gray zones. In the United States, the FDA tightly regulates expanded or culture grown stem cells, but allows some minimally manipulated autologous preparations. Other countries have looser rules, which can attract “stem cell tourism” without strong safety oversight. Cost and access. Many regenerative procedures are expensive and not covered by insurance, putting them out of reach for most patients. Training and standards. “Regenerative medicine” is not a protected term. A weekend course can turn a physician or chiropractor into a self described expert, even if they lack deep training in imaging, anatomy, or orthobiologics. Unrealistic expectations. Marketing often implies near miraculous recovery, which does not align with the incremental gains I typically see in real clinic populations. Beyond those systemic problems, individual patients can experience clear disadvantages: out of pocket costs, travel burden, variable pain during and after procedures, and the emotional toll of hope followed by partial or no improvement. Costs, insurance, and financial realities Money questions come up in almost every consultation. People ask: What is the average cost of regenerative medicine? Will insurance pay for regenerative medicine, or for something specific like Kinetix injections? How much do regenerative medicine doctors make, and does that create conflicts of interest? The financial landscape is complicated and varies widely by country and by procedure, but a few patterns hold in the United States. For musculoskeletal regenerative procedures such as PRP or bone marrow derived cell injections, typical cash prices range from about 500 to 2,000 USD for standard PRP, and 2,000 to 8,000 USD or more for stem cell based procedures involving bone marrow or adipose tissue. Complex multi site treatment plans can exceed those numbers. What is the average cost of regenerative medicine, broadly speaking? If you force a general range, many common orthopedic biologic treatments land somewhere between 1,500 and 6,000 USD per episode of care, depending on complexity and geography. Will insurance pay for regenerative medicine? For most biologic injections, the current answer in the United States is no. Some carriers are beginning to reimburse certain PRP indications, and occasionally adjunctive biologics used during surgery, but the majority of PRP and cell based procedures remain self pay. Patients specifically ask: Does insurance cover Kinetix? Kinetix is a brand associated with certain regenerative or orthobiologic treatments marketed for joint pain. Coverage depends on the exact product, how it is billed, and the insurance plan, but practically speaking, most insurers still categorize these treatments as experimental and deny payment. I always tell patients to assume a cash model unless they see a written preauthorization from their insurer. On the physician side, how much do regenerative medicine doctors make is hard to answer precisely, because very few are coded as such. Income tracks more with the underlying specialty. In most surveys, the highest paid doctor specialty categories include neurosurgery, orthopedic surgery, cardiology, and some interventional fields, often in the 600,000 to 1,000,000 USD per year range at the top end. The lowest paying doctor specialty categories tend to include pediatrics, family medicine, and some primary care oriented fields, often in the 200,000 to 260,000 USD per year range. A regenerative medicine oriented orthopedist who runs a high volume cash-based clinic will sit much closer to the high income side than a primary care physician who occasionally refers for PRP. Financial incentives do matter. When a physician’s income depends heavily on performing expensive, non covered injections, patients have to rely even more on the doctor’s integrity. I encourage people to ask directly about success rates, alternatives, and whether the physician would recommend the same procedure to a close family member. Pain, success rates, and who makes a good candidate Another frequent concern is whether regenerative medicine is painful. Most regenerative injections involve needles, sometimes guided by ultrasound or fluoroscopy. With good local anesthesia, many patients describe the procedures as uncomfortable but tolerable, similar to a dental visit. The post procedure period can be more challenging, especially with PRP or bone marrow derived injections to joints or tendons, because we often provoke inflammation as part of the healing response. Expect soreness that can last days to a couple of weeks, along with temporary activity restrictions. What is the success rate of regenerative medicine? That phrase is almost meaningless without specifying the condition, the treatment, and the definition of success. For example: PRP for chronic tennis elbow has reasonable data suggesting that a majority of patients, often in the 60 to 80 percent range, report meaningful pain reduction and functional improvement compared with steroid injections or placebo, especially over 6 to 12 months. Stem cell like injections for knee osteoarthritis show a more mixed picture. Some trials and case series report significant pain relief and functional gains in perhaps half to two thirds of patients, others show more modest or no benefit compared with hyaluronic acid or physical therapy. Structural regeneration of cartilage visible on MRI is less consistent than symptom relief. Who is a good candidate for regenerative medicine depends on several practical factors: the nature and severity of the injury or degeneration, the patient’s metabolic and overall health status, their willingness to commit to rehabilitation, and their financial situation. A middle aged patient with a focal tendon tear, good metabolic health, and realistic expectations is a far better candidate than someone with end stage bone on bone osteoarthritis who is hoping to avoid an inevitable joint replacement with one injection. Interestingly, fasting and other metabolic interventions can move someone from marginal to better candidate by improving inflammation, insulin resistance, and body weight. I have seen patients who lost 10 to 20 percent of their body weight and improved their sleep and blood sugar achieve better, more durable results from regenerative procedures. Is there a “best country” for stem cell treatment? Patients sometimes phrase it bluntly: What country is best for stem cell treatment? They have heard about Panama, Mexico, Germany, or clinics in Eastern Europe, often through athletes or podcasts. The reality is uncomfortable. Countries like Panama and Mexico host clinics that use cell preparations, doses, and routes of administration that go beyond what is allowed in the United States. Some are run by capable teams with genuine scientific intent, others are barely regulated businesses. Rigorous outcome data across large numbers of patients is sparse. From a strictly evidence based standpoint, no country can honestly claim to be “best” right now. The United States lags in access but has tighter safety oversight for approved uses. Some European systems have strong academic programs, but patients may not qualify for trials. Countries with more liberal regulations offer access, but at the cost of weaker safety and efficacy data. My advice is to focus less on geography and more on: The specific condition you want treated The type of cells and delivery method proposed The clinic’s data, including complication rates and long term follow up The transparency of their consent process and willingness to discuss alternatives A weekend fast at home will not substitute for any of this, but it is a reminder that powerful biological shifts are still accessible without getting on a plane. How to think about 72 hour fasting in a long term plan Instead of chasing a singular “regenerative” fast, I encourage people to think in terms of cycles and context. A person in their 30s or 40s with no major medical issues who eats a whole food diet, maintains a healthy weight, exercises regularly, and sleeps well will get more from an occasional 24 to 48 hour fast than a metabolically unhealthy person will get from a heroic 72 hour water fast once a year. If you are curious and medically appropriate, it is reasonable to: Start with daily time restricted eating, such as a 12 to 14 hour overnight fast, then gradually explore 16 hours once a week. Monitor how your energy, mood, and blood sugar respond. Work with your physician if you take medications, especially for blood pressure, diabetes, or mood disorders. Once you are comfortable and stable with shorter fasts, a carefully planned 24 hour fast can extend the metabolic benefits, often without major side effects. Continue to prioritize hydration, electrolytes, and good nutrition on eating days. Only after you and your clinician are confident about these shorter fasts should you even consider a 48 to 72 hour fast, and even then, it may not add much beyond what consistent, moderate interventions already achieve. Fasting is a tool, not an identity. Used wisely, it can support the same cellular processes that regenerative medicine aims to harness: better autophagy, healthier mitochondria, and more resilient tissues. Used recklessly, it can aggravate underlying conditions and distract from more important work like strength training, blood sugar control, and addressing sleep apnea. The promise of regeneration is seductive, whether it comes from a clinic overseas or a three day fast at home. The real gains usually arrive quietly, over months and years, built from hundreds of small, repeatable choices rather than a single dramatic intervention.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

Regenerative medicine promises something people in pain or facing disability crave most: a second chance. Stem cells, biologics, platelet rich plasma, and exosomes are marketed as ways to repair joints, restore function, even reverse aging. When treatment at home is expensive, not covered by insurance, or simply not offered, patients look abroad. That is the core of regenerative medicine tourism. I have sat with patients who returned from overseas stem cell injections confused, relieved, or devastated. A few felt somewhat better. Several were unchanged after spending more than their annual income. A small but important number came back sicker than when they left, with infections, blood clots, or empty savings accounts. The pattern is consistent enough that it is worth examining closely. This article focuses on the disadvantages, especially the financial and medical downsides, of traveling abroad for regenerative therapies. It is not an attack on the science of regeneration. There is genuine promise in this field. The problem is how that promise is packaged, priced, and delivered to desperate people who are often running out of options. What regenerative medicine is really offering Regenerative medicine is an umbrella term. At its best, it includes carefully designed therapies that aim to repair, replace, or regenerate diseased tissues. In research settings, this might mean engineered tissues for burned skin, lab grown organs, or gene editing for rare disorders. In day to day clinical marketing, however, it usually refers to things like: Autologous cell procedures, such as bone marrow or fat derived cells that are concentrated and injected. Biologic preparations, such as platelet rich plasma (PRP) or amniotic products. Experimental stem cell infusions, often from birth tissue or cord blood. When people ask, “What is a regenerative medicine doctor?” the answer varies. In reputable centers, this is usually a physician with training in orthopedics, physical medicine and rehabilitation, sports medicine, hematology, or another specialty, who then develops expertise in cell and tissue based therapies. In other settings, particularly some high volume clinics abroad, “regenerative doctor” can be a cosmetic physician, a general practitioner, or occasionally someone with minimal postgraduate training. That variability alone introduces risk. The same technology in the hands of a boarded orthopedic surgeon with research experience is not equivalent to a spa-like clinic offering “anti aging stem cell drips” to anyone who pays cash. The allure of treatment abroad: price, access, and celebrity stories When patients weigh regenerative medicine in their home country, they quickly run into three barriers: cost, coverage, and caution. First, cost. People routinely ask, “What is the average cost of regenerative medicine?” In the United States for example, a single PRP injection might run 500 to 1,500 dollars. Bone marrow derived cell injections for joints might fall in the 3,000 to 8,000 dollar range per joint. Some multi day protocols with repeated injections can exceed 15,000 dollars. Full body stem cell infusions marketed for “rejuvenation” or neurologic conditions can run even higher. Second, coverage. “Will insurance pay for regenerative medicine?” In most countries with private insurance or mixed systems, the answer is largely no for elective orthopedic and anti aging uses. Insurers often classify these interventions as experimental, especially for arthritis, tendon pain, spinal conditions, or generalized wellness. Some limited use cases, such as certain bone marrow transplants in oncology or specialized wound healing products, are covered because they passed rigorous trials. Popular outpatient stem cell injections typically have not. That is why questions like “Does insurance cover Kinetix?” come up. Kinetix is one of many branded biologic or injection based therapies marketed for joint and soft tissue problems. Coverage is inconsistent, and often nonexistent, particularly when the product is pitched as regenerative or anti aging rather than as a standard orthopedic or rheumatologic treatment. Patients end up paying cash. Third, caution. Regulatory agencies in higher income countries restrict unproven uses of stem cells and related products. That frustrates patients who see online testimonials, podcasts, and videos promising dramatic improvements. When their local specialist says, “We do not offer that, the data are not there yet,” they feel blocked. Then they hear that Joe Rogan went to Panama for stem cell infusions. He has described treatments at a clinic in Panama City using large dose intravenous stem cells for joint pain and general recovery. Clinics in Mexico, Costa Rica, Colombia, Thailand, and Eastern Europe actively market similar protocols. When a patient hears, “Where did Joe Rogan get his stem cell treatment?” and discovers it was abroad, it reinforces the idea that “the good stuff” is offshore. Combine all of that with glossy websites that quote prices lower than domestic clinics, and regenerative medicine tourism becomes tempting. The quiet reality of the price tag From the outside, traveling to another country for treatment looks cheaper. A clinic might advertise a “comprehensive stem cell package” for 8,000 dollars that includes injections, hotel, and transportation, compared with 15,000 dollars at a local center just for the procedure. Patients understandably think they will save money. Costs tend to multiply in ways that are easy to underestimate. Travel for the patient and often a companion, hotel nights beyond the “package,” missed work, meals, and last minute incidentals all add up. If complications occur, the math becomes brutal. When people ask, “What is the average cost of regenerative medicine?” abroad, a realistic range for popular stem cell tourism packages is 5,000 to 25,000 dollars depending on the country, the number of treatment days, and how many sites are injected. That does not include flights. Some neurologic or “full systemic” packages for conditions like ALS, multiple sclerosis, or autism push beyond 30,000 dollars. Financially, the biggest unresolved question is not the sticker price. It is value. You might save 30 percent on the initial procedure but still receive care that is poorly standardized, weakly supported by evidence, and hard to follow up on. If you need revision surgery at home, prolonged physical therapy, or hospitalization for a complication, your net cost over two years can easily double. From a practical standpoint, another hidden cost is opportunity. Money spent on unproven regenerative therapy is money that cannot be used for interventions with stronger data, such as structured physical therapy, weight loss programs, joint replacement when indicated, or high quality pain management. Patients often tell me, “I thought this would keep me from needing surgery.” Two years later, they still get the surgery, but with less savings and more scar tissue from multiple injections. The medical downside: risk without clear benchmarks The critical scientific question in this field often gets framed as “What is the biggest problem with regenerative medicine?” In research circles, the key issue is that the biology is complex and slowly evolving, while the commercial market moves fast. Many marketed uses are ahead of the data. For tourism specifically, the biggest problem is that medical risk is detached from normal safeguards. A few points illustrate why this matters. Regulatory variability means that the same product could be treated as a medication, a tissue, a surgical procedure, or a wellness service depending on the country. That affects manufacturing oversight, sterility standards, and adverse event reporting. Dosing and source of cells differ widely. Two “stem cell injections” might involve completely different cell types and counts, processed in different ways, with different likelihoods of surviving or doing anything useful in the body. Clinical protocols are rarely standardized. In orthopedics, for example, one clinic might inject bone marrow concentrate into the knee under ultrasound guidance once, another might combine fat derived cells, PRP, and ozone in multiple sessions, yet both advertise similar claimed success rates. Patients often ask, “What is the success rate of regenerative medicine?” An honest answer is that it depends entirely on the specific condition, the type of treatment, the severity of disease, and what you call success. For mild tendon problems treated with PRP in a well designed trial, success might mean reduced pain and improved function in 60 to 80 percent of carefully selected patients. For severe bone on bone arthritis injected with unproven stem cell cocktails, true durable improvement may be far lower than what marketing suggests. In a tourism context, reported success rates are typically self published numbers without independent auditing. A clinic might claim 85 percent success for spinal cord injury based on its own follow up surveys with no clear definition of outcome. Patients seldom see the full denominator, including those who did not respond or who had harm. Pain, discomfort, and what the procedures really feel like A common counseling conversation centers around “Is regenerative medicine painful?” It depends on the procedure. Blood draws for PRP are minor, though the injection into a tendon or joint can sting and ache for a few days. Bone marrow aspiration can be quite uncomfortable without proper anesthesia or sedation, and even with good technique patients often describe a deep ache afterward. When I see patients who went to overseas clinics, their stories vary. Some say, “It hurt less than I expected, they numbed everything well.” Others describe repeated spinal or joint injections done quickly, sometimes by non physicians, with minimal explanation. Bruising, swelling, and short lived flares in pain are common. Those are acceptable risks when the potential benefit is clear and the clinician is accountable. In tourism settings, it is harder to know who is responsible if something goes wrong two weeks later in another country. Full body intravenous infusions tend to be physically easier in the moment. The issue there is less the acute discomfort and more the unknowns about where these cells travel, how long they survive, and whether they could lodge in lungs or form unwanted growths. That risk may be small, but without rigorous trials, no one can quantify it confidently. Misunderstood biology: fasting, “rejuvenation,” and what regeneration means The term regeneration is heavily abused in marketing. Patients hear about “resetting the immune system,” “turning on stem cells,” or “activating longevity pathways” through both medical procedures and lifestyle hacks. A common question is, “Does fasting for 72 hours regenerate cells?” The honest answer is that extended fasting in animal models and some small human studies can influence markers of autophagy, insulin sensitivity, and certain immune cell populations. However, saying that a three day fast “regenerates” entire organs or reverses chronic joint damage is a leap far beyond the data. It might modestly improve metabolic health in some people, but it is not a replacement for structural repairs or carefully tested cell therapies. Even within formal biology, “What are the 4 types of regeneration?” depends on context. In classical developmental biology, researchers talk about epimorphosis, morphallaxis, compensatory regeneration, and superregeneration. These describe how organisms like salamanders and planaria regrow body parts. In clinical regenerative medicine, people instead refer to categories like cellular therapies, tissue engineering, gene based therapies, and biologic scaffolds. Tourism marketing often blurs all of these, using the language of salamanders to sell intravenous drips in a hotel setting. The main problem is that nuanced laboratory findings get turned into absolute claims: “We can regrow cartilage,” “We can regenerate your spine.” For advanced bone on bone arthritis, that is more hope than reality at present. Who is actually a good candidate, and who is not “Who is a good candidate for regenerative medicine?” is a fair question. Reasonable candidates often share a few traits: a clear diagnosis; mild to moderate structural damage; failure of conservative measures like physical therapy and targeted injections; overall good health; and realistic expectations. For example, a middle aged recreational runner with a partial Achilles tendon tear that has not improved after months of rehab might reasonably consider PRP with a qualified sports medicine specialist. Poor candidates tend to be those with advanced structural collapse, severe deformity, or long standing neurologic damage where basic anatomy is profoundly altered. A hip joint with no remaining cartilage, bone spurs, and major loss of motion is unlikely to be restored by any injection, regardless of branding. Similarly, late stage ALS or advanced spinal cord transection has no convincing evidence of meaningful reversal through offshore stem cell infusions, despite aggressive marketing. In tourism settings, financial incentives push clinics to broaden the definition of a “good candidate” to almost anyone with a credit card. That is where harm often begins. Patients with minimal chance of benefit are told they should try because “you never know” and “it could regenerate.” This bypasses one of the most important safeguards in medicine: the honest conversation about when treatment has more downside than upside. The training and income reality behind regenerative medicine clinics Many patients assume that a “stem cell center” is staffed by highly specialized physicians in a very high earning niche. They wonder, “How much do regenerative medicine doctors make? Is this a special elite group?” In reality, income varies as much as in other specialties. Physicians who offer regenerative options are often orthopedic surgeons, sports medicine doctors, physiatrists, anesthesiologists in pain medicine, or dermatologists in cosmetic settings. Some work in academic centers with salaried positions. Others run cash based clinics where revenue depends on procedure volume. In the broader medical landscape, “Who is the highest paid doctor specialty?” is usually answered by pointing to neurosurgeons, thoracic surgeons, and certain orthopedic subspecialists, whose median incomes can reach Regenerative Medicine Doctor Scottsdale 700,000 to 900,000 dollars or more in high compensation markets. At the other end, “What is the lowest paying doctor specialty?” often includes pediatrics, preventive medicine, or family medicine, where median incomes are frequently less than half that. Regenerative offerings sit inside that range, not above it. Income depends less on the label of regenerative medicine and more on the underlying specialty and business model. Tourism clinics sometimes lean heavily on marketing because they are not anchored by a robust local patient base or insurance contracts. That pressure can influence how aggressively they recommend procedures. Country shopping: “best place for stem cells” and why that framing is risky People often ask online, “What country is best for stem cell treatment?” It is the wrong question. It treats stem cells like a consumer product: the same everywhere, just cheaper or stronger in certain markets. In truth, the quality of care depends more on the specific clinic, its protocols, oversight, and ethics than on the flag it operates under. Some countries have invested heavily in legitimate regenerative medicine research and have excellent academic centers. Others largely host stand alone private clinics that cater to foreigners. The absence of strict regulation does not mean a country is “better” for patients. It usually means less data, less recourse if you are harmed, and more creative marketing. Regenerative medicine tourism also complicates follow up. If you develop an infection in a joint injected overseas, your local orthopedic surgeon has to figure out what was injected, how it was processed, and whether it might harbor atypical organisms. Offshore clinics rarely share detailed product information or batch testing data. Even when they are willing, language barriers and documentation gaps make it difficult. From a purely financial and safety standpoint, the safest “country” is often the one where you can verify the clinician’s training, understand the regulatory rules, access transparent outcome data, and obtain follow up care without crossing borders. Red flags to recognize before booking a flight Because the field is noisy and confusing, a brief checklist helps patients sort the most concerning situations from the merely imperfect. Below are common warning signs that a regenerative medicine tourism offer may carry high risk with little realistic upside. The clinic claims to treat almost any condition, from autism to Parkinson’s disease to arthritis to anti aging, with essentially the same cell product. Reported “success rates” are extremely high, such as 90 percent or 100 percent, with no clear description of how success is defined or measured. Payment is required fully in advance, with steep penalties for cancellation and heavy pressure to commit quickly to lock in a “promotion.” Staff avoid direct answers about who manufactures the cells, how sterility and viability are tested, and whether any regulators oversee their operations. The clinic relies heavily on celebrity testimonials, podcast appearances, and social media influencers, while providing very little peer reviewed data. If several of these are present, the disadvantages of tourism are likely to outweigh any theoretical benefit. The legal and insurance vacuum One of the least appreciated disadvantages of regenerative medicine tourism is legal vulnerability. If you suffer a major complication at a foreign clinic, your ability to seek compensation depends on that country’s legal system, not your own. Some jurisdictions have weak malpractice frameworks, caps so low they barely cover hospital costs, or processes that are slow and inaccessible to non residents. Insurance rarely helps. Travel insurance policies almost always exclude medical complications from elective treatments, particularly those labeled experimental. Health insurance in your home country may cover the emergency management of a complication after you return, but not the root cause or the original procedure. If you ask your insurer before traveling, “Will insurance pay for regenerative medicine?” or “Does insurance cover Kinetix?” the likely answers are no and no, especially when treatment occurs abroad at a non contracted facility. That legal and financial gap shifts almost all the risk onto the patient. It is one thing to take that risk for a life saving cancer surgery that is unavailable at home. It is quite another to take it for an injection series with uncertain benefit for chronic pain. Disadvantages that persist even when nothing “goes wrong” The harm from tourism is not limited to dramatic infections or legal disputes. There is a quieter category of loss that I see repeatedly: patients spend large sums for minimal or temporary change, then feel discouraged and distrustful of all medicine, including genuinely useful options. “What are the disadvantages of regenerative medicine?” in this practical sense include emotional and psychological costs. When someone empties a retirement account for two weeks at a stem cell resort and comes home the same or worse, it often erodes their willingness to engage with rehabilitation, mental health support, or surgical options that might actually help. They feel tricked or foolish, even though their decision emerged from real suffering and hope. There is also the problem of delay. I have seen patients put off needed joint replacement for three to five years while they chase overseas “regeneration.” By the time they accept surgery, their muscles are weaker, their balance is poorer, and their recovery is harder. In spinal problems, delayed decompression can mean permanent nerve damage that could have been avoided Regenerative Medicine Doctor Scottsdale with timely intervention. From a public health perspective, widespread tourism also muddies data collection. Complications treated at home are rarely linked back to the offshore clinic in any registry. That allows risky practices to continue largely unchallenged, while responsible researchers struggle to recruit patients for controlled trials. How to protect yourself if you are still considering it Some patients will pursue regenerative medicine abroad regardless, either because their condition feels desperate or because domestic options are too limited. The goal then becomes harm reduction. A short set of questions can dramatically improve the chances of making a sound decision. What exactly is being injected or infused? Ask for the cell source, processing method, typical cell counts or concentrations, and sterility testing procedures, in writing. What peer reviewed evidence exists for this specific protocol in patients like you, with your diagnosis and disease stage? General “stem cell success” stories do not count. Who is performing the procedure, what is their core specialty, and how are complications such as bleeding, infection, or embolism managed on site? How is follow up handled once you return home, and will the clinic share full records and product details with your local physicians? What happens if something goes seriously wrong, both medically and financially? Clarify emergency plans, transfer agreements with local hospitals, and any malpractice coverage. If a clinic cannot answer these questions clearly, or reacts defensively when you ask, that is a signal to step back. Regenerative medicine as a scientific field deserves careful, methodical development. Some applications, such as cellular therapies for certain blood cancers or engineered skin for severe burns, already save lives and restore function. Others, particularly many of the offerings marketed to medical tourists, are still speculative. The core disadvantage of regenerative medicine tourism is not that travel is inherently bad or that foreign doctors are less skilled. It is that tourism often combines the highest levels of patient vulnerability with the lowest levels of oversight, transparency, and long term accountability. When that combination is paired with high financial cost and uncertain benefit, the balance tilts against the patient. Anyone contemplating a flight for stem cells or other regenerative procedures should slow down, gather data, and evaluate not only the promise but also the full price, in money, risk, and lost alternatives.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

If you spend any time around orthopedic or sports medicine clinics, you will hear the same question again and again, usually asked in a low voice, after all the technical explanations are done. "Okay, but how much is this going to hurt?" Regenerative medicine lives in that awkward space between hope and fear. Hope that your knee, shoulder, back, or tendon might heal without surgery. Fear of needles, of unknown treatments, of horror stories from a friend of a friend whose injection was "the worst pain of my life." As someone who has watched hundreds of patients go through regenerative procedures, the pattern is clear. The pain is real, but it is usually short‑lived, highly variable, and often manageable with good planning and honest expectations. This is a practical walk through what regenerative medicine feels like, who is a good candidate, what it costs, how insurance fits in, and what the evidence really says about risk, pain, and benefit. What a regenerative medicine doctor actually does Before talking about pain, it helps to be precise about who we are talking about. What is a regenerative medicine doctor? In most cases, it is not a separate residency. It is a physician who comes from a "home" specialty such as: Physical medicine and rehabilitation (PM&R) Sports medicine Orthopedic surgery Interventional pain management Rheumatology or internal medicine with additional training They then complete focused training or fellowships in regenerative techniques: platelet‑rich plasma (PRP), bone marrow or fat‑derived cell harvesting, image‑guided injections, sometimes lab‑based work in cell processing. On a typical clinic day, a regenerative medicine doctor evaluates joint or tendon pain, reviews imaging, performs diagnostic injections, and then, when appropriate, performs procedures that try to stimulate healing rather than just reduce symptoms. The work lives somewhere between traditional orthopedics and interventional pain procedures. As for how much regenerative medicine doctors make, their income is closer to their base specialty than to some fantasy "stem cell millionaire" stereotype. In the United States, many land in the 250,000 to 500,000 dollars per year range, depending on: Base specialty and geography How much of their practice is procedural Whether they own their facility or work in a hospital system How much of their work is cash‑pay versus insurance They are not typically the highest paid doctor specialty. Orthopedic surgery, plastic surgery, cardiology, and some radiology subspecialties consistently outrank them on compensation surveys. On the other end, the lowest paying doctor specialties tend to be primary care fields such as pediatrics and family medicine, especially in non‑procedural roles. The core question: is regenerative medicine painful? Short answer: it can be, but usually in short, predictable windows. The severity depends on three things. First, what is being injected and where. A small PRP injection into a relatively superficial tendon is very different from a deep injection into a joint or spine structure. Second, how the procedure is done. Ultrasound or fluoroscopy guidance, local anesthetic technique, and the specific needle path all matter. Third, your own biology and history. People with central sensitization, fibromyalgia, prior traumatic medical experiences, or high baseline anxiety often experience more pain and longer flares. Most musculoskeletal regenerative procedures follow a similar pattern: Brief procedural discomfort Several hours of numbness or partial relief from local anesthetic A "pain flare" as the anesthetic wears off and the injected material irritates tissues Gradual settling over 2 to 10 days In many clinics, patients rate procedural pain in the 3 to 7 out of 10 range. A few report higher peaks, particularly with dense PRP or multiple needle passes through tight tissue. Very rarely, the wrong plan or poor technique can turn a reasonable procedure into a miserable experience. Technique and preparation matter. What different regenerative procedures actually feel like Patients usually do better when they have a concrete sense of what they will experience. Details defuse fear. Platelet‑rich plasma (PRP) PRP is probably the most common regenerative treatment. Blood is drawn from your arm, spun in a centrifuge to concentrate platelets, then reinjected into the target area. The blood draw is no more painful than standard lab work. The injection is the part most people worry about. For joints such as knees, hips, or shoulders, the physician numbs the skin and often the deeper tissue with a local anesthetic first. You feel a quick sting with the numbing, then pressure or a dull ache as the PRP is injected. The joint can feel uncomfortably full for several hours. For tendons, like tennis elbow or Achilles tendinopathy, the technique often involves "peppering" the diseased tendon with multiple tiny needle passes. The numbing helps, but once the anesthetic fades, patients often feel a deep, throbbing soreness that can peak over 24 to 72 hours. Walking on an injected Achilles tendon, for example, can be quite sore for several days. In my experience, people who do well with dental procedures under local anesthesia usually handle PRP without major trouble. Those who nearly faint at a flu shot may need more hand‑holding, distraction techniques, or even anxiolytic medication. Bone marrow or fat‑derived cell procedures Some regenerative clinics perform bone marrow aspirate concentrate (BMAC) or harvest stromal vascular fraction from fat. These are more involved than PRP. Bone marrow is usually taken from the back of the pelvic bone. The skin and tissues are numbed, sometimes with additional light sedation. Patients often describe a strong, deep pressure and sometimes a short, sharp bolt of pain when the marrow is actually aspirated. It is uncomfortable, but the Pain with a capital P moment is measured in seconds. The re‑injection part feels similar to PRP: joint pressure, a sense of fullness, then post‑procedure soreness. Fat harvesting, often from the abdomen or flank, feels similar to a small‑volume liposuction. With good local anesthesia, most patients report pressure, tugging, and mild burning rather than overt pain. Bruising and soreness can linger for days. Prolotherapy and other irritant injections Traditional prolotherapy uses dextrose solutions or other irritants to provoke a controlled inflammatory response. The injection pattern can involve many small injections in a region. Even with numbing, this can feel like an extended vaccination session focused on one area. Burning, stinging, and mechanical soreness build up. Patients who expect "this might sting 20 or 30 times, but it will end" usually cope better than those who were hoping for one quick poke. Shockwave and non‑injection therapies Not all regenerative approaches involve needles. Shockwave therapy, for example, uses targeted mechanical waves to stimulate healing in tendons and fascia. It is often described as a series of sharp taps or deep pounding over the sore spot. The intensity is adjustable. Most clinics start lower and build up to a tolerable but intense level. The session lasts minutes, not hours. Laser therapies, blood flow restriction training, and certain biologic patches are usually better tolerated, with more of a warmth or pressure sensation than outright pain. The "after" phase: pain flares and healing curves Many patients expect the procedure day to be the worst part. In reality, the day or two after can feel rougher, especially once the local anesthetic has worn off. For joint PRP, a common pattern goes like this: you walk out of the clinic mildly sore but moving reasonably well. Six to eight hours later, pain starts climbing. By the next morning, the joint feels stiff, hot, and angry. That peak phase usually lasts between 24 and 72 hours, then slowly tapers. For tendons, the flare can be even more focused. That Achilles, elbow, or patellar tendon may feel like someone turned up the volume on your original pain. Normal walking or light use can provoke sharp jabs. Rest, protected weight‑bearing, and cold packs help. So does knowing this is expected, not a sign of harm. This is where the fear of pain can sabotage outcomes. If a patient is not prepared, they often panic, stop moving completely, or start taking every anti‑inflammatory medication they can find. High‑dose NSAIDs right after regenerative procedures might blunt the healing response you paid for. Most protocols prefer acetaminophen, judicious use of prescribed medications, and simple comfort measures such as ice or contrast therapy. Over the next 2 to 6 weeks, pain usually shifts from an acute flare to a quieter background ache that gradually improves. Genuine tissue change takes time. If someone expects to wake up "fixed" a week after a severe tendon or joint injection, they are almost guaranteed to be disappointed. Who is a good candidate for regenerative medicine? The question is not just "Can this help me?" It is also "Am I the right person to go through this kind of process?" People who tend to do well share a few traits: They have a fairly clear structural problem: chronic tendinopathy, early to moderate osteoarthritis, focal ligament injury, or a well‑defined pain generator. They have tried and stuck with standard care first: physical therapy, exercise modification, basic injections when appropriate, weight management. They understand that regenerative medicine aims to nudge healing, not magically rebuild a destroyed joint. They can tolerate short‑term discomfort and downtime for a potential long‑term gain. They have realistic financial expectations and have thought through the cost. On the other hand, people with widespread unexplained pain, severe joint collapse, or complex systemic illness may not be ideal candidates. In those cases, regenerative procedures can add pain and expense without much benefit. This connects to a broader question: what is the biggest problem with regenerative medicine? It is not the needles. The real problem is expectation mismatch, driven by aggressive marketing and uneven regulation. Too many clinics present these treatments as guaranteed "cures" rather than biologically plausible options with variable success rates. How successful is regenerative medicine, really? Asking "What is the success rate of regenerative medicine?" Is a bit like asking, "What is the success rate of surgery?" It depends entirely on what is being treated, by whom, and how you define success. In literature on PRP for certain tendinopathies, such as tennis elbow or patellar tendinopathy, responders often fall in the 60 to 80 percent range for meaningful pain reduction over several months. For knee osteoarthritis, numbers are more modest and vary widely, but many studies show better symptom control than placebo or hyaluronic acid over 6 to 12 months in early to moderate disease. BMAC and fat‑derived cell therapies have promising but less standardized data. Many trials are small, designs vary, and regulatory constraints limit how aggressively these approaches can be studied and standardized in some countries. The pattern is consistent: Best outcomes occur in earlier disease, when there is still something to salvage. Success is higher when regenerative procedures are paired with strong rehabilitation and lifestyle changes. Smoking, uncontrolled diabetes, obesity, and poor sleep habits drag results down. There are also clear disadvantages of regenerative medicine. Cost sits at the top of the list. Variability in preparation techniques, especially with so‑called "stem cell" therapies, is another. And although serious complications are rare in experienced hands, they do occur: infection, bleeding, nerve irritation, worsening pain, or, in very rare spine procedures, catastrophic events. Cost, insurance, and the reality of paying for pain When people ask, "Will insurance pay for regenerative medicine?" They are usually asking about PRP and cell‑based treatments. In many countries, the answer is "not yet" or "very selectively." In the United States, most commercial insurers and Medicare do not cover PRP or bone marrow concentrate for common musculoskeletal uses, although some niche indications and plans are starting to open. That means most patients pay out of pocket. What is the average cost of regenerative medicine? It varies by region and by procedure, but reasonable ranges look like this for musculoskeletal work: PRP for a single joint or tendon: roughly 500 to 2,500 dollars per treatment Bone marrow or fat‑derived injections: 3,000 to 8,000 dollars or more, especially when multiple sites are treated Shockwave therapy packages: a few hundred to a couple thousand dollars for a series of sessions Some branded programs, such as Kinetix or similar proprietary protocols, are marketed as package deals that bundle imaging, multiple injections, and rehab. Does insurance cover Kinetix? For most commercially branded regenerative packages, the answer is no. You might get coverage for standard components like physical therapy or imaging, but not for the biologic injections themselves. This is one reason regenerative medicine doctors are often cautious with indications. If they know the patient is paying substantial sums for something that may not work, the threshold for recommending it should be higher, not lower. Where people travel for treatment: Joe Rogan, Panama, and medical tourism Whenever stem cell therapy comes up, someone mentions celebrities. "Where did Joe Rogan get his stem cell treatment?" He has publicly discussed traveling to Panama for intravenous and targeted stem cell therapies, specifically to the Stem Cell Institute in Panama City. That clinic operates under Panamanian regulations which allow procedures that are not approved in the United States. So what country is best for stem cell treatment? There is no simple answer, and anyone who declares a single "best" country is usually selling something. The United States and many European countries prioritize safety and strict oversight, which often slows expansion but protects patients. Regenerative Medicine Doctor Scottsdale Other countries have more permissive frameworks that allow treatments with less robust evidence. Medical tourism can make sense in rare cases, but it brings its own risks: Difficulty verifying standards Challenges with follow‑up care Limited recourse if something goes wrong The pain here is not just physical. It is the psychological stress of navigating high‑stakes decisions in an international gray zone. Where does "regeneration" really come from? Four types and a fasting myth The phrase "What are the 4 types of regeneration?" Floats around in both biology textbooks and lay articles, but people often mean different things. In classical biology, regeneration is categorized into types such as: Epimorphic regeneration, where a structure like a limb regrows from a mass of undifferentiated cells. Morphallactic regeneration, where existing tissues reorganize without major cell division. Compensatory regeneration, where remaining tissue expands to compensate, like the liver growing back after partial removal. Tissue‑specific or cellular regeneration, where specific cells such as blood cells are continually replenished. In clinical regenerative medicine, we often talk less about these formal categories and more about four practical pillars: cell therapies, tissue engineering, biomaterials, and biologics or small molecules that stimulate repair. When patients ask, they usually want to know if we are actually regrowing their cartilage or tendon, or just improving function. Related to this is a very different Regenerative Medicine Doctor Scottsdale kind of regeneration question: does fasting for 72 hours regenerate cells? Some animal studies and small human trials suggest that prolonged fasting triggers autophagy and changes in immune cell populations, with potential benefits for cellular housekeeping and metabolic health. There is cautious evidence that longer fasts can alter stem and progenitor cell behavior in specific contexts. But it is a leap to claim that a 72‑hour fast "regenerates" joints or tendons in the way a targeted injection might. Fasting is a metabolic intervention, not a localized structural repair tool. It can be part of a global health strategy, but it is not a substitute for carefully delivered regenerative procedures when you have a focal, mechanical problem. Managing fear of pain: practical strategies that work The same procedure can be a 4 out of 10 experience for one person and a 9 out of 10 for another, purely based on preparation and mindset. Patients who cope well tend to: Have a clear, frank conversation with their physician about what is likely to hurt and for how long, rather than vague reassurances. Arrange their schedule so they can genuinely rest for a few days without pressure to push through important events. Prepare simple comforts in advance: ice packs, easy meals, pillows to position the treated limb, entertainment. Decide in advance what medications are allowed, in what doses, and under what red‑flag circumstances they should call the clinic. Have one supportive person who knows the plan and will not panic on their behalf if pain flares. In clinic, it is often the unspoken fear that causes the most distress. People imagine nerve‑shredding agony or permanent damage. Once they understand that the worst pain is usually minutes to days, that most flares settle, and that help is available if something feels off, their shoulders drop a little and the entire process smooths out. If someone has a trauma history, needle phobia, or existing chronic pain amplification, that should not automatically exclude them from regenerative options. But it does call for extra care: perhaps a pre‑procedure visit just to walk through the room and equipment, or coordination with a therapist who can provide grounding strategies. Where regenerative medicine fits among medical careers A brief detour back to the professional side, because patients sometimes ask surprisingly detailed questions about medical training and pay during these visits. Who is the highest paid doctor specialty? Surveys change year to year, but orthopedic surgeons, plastic surgeons, cardiologists, and neurosurgeons often top the charts in the United States. Regenerative medicine physicians who come from PM&R or primary care‑based sports medicine usually sit below those surgical giants, though procedural work can boost income. At the bottom of pay scales, the lowest paying doctor specialty categories generally include pediatrics, family medicine, and some psychiatry and public health roles, particularly in non‑procedural, salaried positions. Why mention this in an article about pain? Because the financial structure of medicine shapes how treatments are offered. Procedures that pay well under insurance risk being overused. Treatments that are time‑intensive but poorly reimbursed risk being underused. Cash‑pay regenerative medicine can drift in either direction: under‑offered in cautious systems, over‑hyped in entrepreneurial ones. Understanding these pressures makes it easier to interpret the advice you are getting. Putting it all together: is it worth going through the needles? If you strip away marketing language, the core questions become very simple. Is regenerative medicine painful? Yes, in most cases you can expect at least short‑term discomfort, often moderate, occasionally intense. That pain is usually brief, modifiable, and largely predictable with good technique. Is the pain justified by the outcomes? Sometimes. When a well‑selected patient with a stubborn tendon problem gets 60 percent less pain and can return to sport after a single PRP series, the week of soreness feels small in hindsight. When someone with advanced "bone on bone" arthritis spends thousands on a cell‑based injection and feels no change, the memory of those needle passes sharpens. Could careful fasting, supplements, or exercise alone regenerate the tissue? Not in the structural, localized way most injured joints and tendons need. Those strategies are important background players, not lead actors. The best use of regenerative medicine sits in the middle ground. Not as a miracle that replaces all other care, not as a scam to be dismissed outright, but as one more tool with specific strengths and limits. If you are considering a procedure, ask your doctor to talk not just about molecules and MRI findings, but about sensations and pain: Where exactly will the needle go? How long will it take? How do patients in your practice usually describe it? What is your plan for the first three days afterward? What will you do if my pain is worse than expected? Good regenerative medicine starts there, in that honest conversation about needles, nerves, numbing, and the very human fear of hurting in the name of healing. Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823

Regeneration sounds almost mythical when patients first hear it. The idea that damaged joints, nerves, or even organs might repair themselves feels closer to science fiction than to clinic room reality. Yet the body regenerates quietly every day, and modern regenerative medicine tries to harness that built‑in capacity in a more deliberate way. When people ask, “What is a regenerative medicine doctor?” they are usually not asking about definitions from a textbook. They want to know what those physicians actually do, whether it hurts, if it works, whether insurance will pay for regenerative medicine, and how to tell if they are a good candidate. To answer those questions meaningfully, it helps to start with a clear picture of what regeneration is and the main ways it happens in the body. What doctors mean by “regeneration” In simple terms, regeneration is the process by which the body replaces or restores cells, tissues, or organs that are damaged, lost, or worn out. Some of that is entirely routine. Your intestinal lining turns over every few days. Your skin replaces itself continuously. Bone is constantly being broken down and rebuilt. That is regeneration at work, even if you never notice it. Other times, regeneration is a response to injury: a broken bone knitting, a liver recovering after part of it is removed, or a child’s fingertip growing back if the injury occurs at the very tip. Clinically, when we talk about regenerative medicine, we mean treatments that aim to enhance, guide, or mimic those natural repair processes. Examples include platelet‑rich plasma (PRP), bone marrow or fat‑derived cell concentrates, certain stem cell protocols in research settings, biologic scaffolds, and, emerging now, gene and cell‑based therapies. Before we get to those techniques, it helps to sort out the basic biology. The 4 types of regeneration: a clinically useful framework Biology textbooks use a few different ways to classify regeneration. You might see categories like epimorphic or morphallactic regeneration in courses that cover salamanders and planaria. Clinicians rarely speak that way with patients. In practical, human medicine, the 4 types of regeneration that matter most are: Physiologic regeneration Reparative regeneration Compensatory regeneration Induced (or therapeutic) regeneration Different authors use slightly different labels, but this four‑part framework maps well to what we actually see in clinic and operating rooms. 1. Physiologic regeneration: the quiet background work Physiologic regeneration is the ongoing, normal turnover of cells and tissues in a healthy body. Nothing dramatic triggers it, and it does not feel like healing because there is no obvious injury. Your body is a mosaic of tissues with very different regenerative tempos. Skin and gut lining turn over quickly. Liver and bone regenerate more slowly. Neurons in the brain barely regenerate at all, if they do. Practical examples: Skin: Keratinocytes in the epidermis are replaced roughly every 4 to 6 weeks. Gut: The intestinal epithelium can turn over in 3 to 5 days. Blood: Most white blood cells and platelets last days to weeks; red blood cells last about 3 months, then are replaced. Bone: Entire skeletal remodeling cycles may take 7 to 10 years, although specific areas turn over faster. Clinically, physiologic regeneration matters because it sets the baseline. When the body is sleep‑deprived, malnourished, inflamed, or overloaded with toxins, this quiet background work slows or becomes disorganized. That is part of why lifestyle changes often matter more than any injection or drug, especially in chronic musculoskeletal pain. It is also where questions like “Does fasting for 72 hours regenerate cells?” show up. Prolonged fasting has been shown, in animal models and some early human data, to trigger stronger autophagy (cellular clean‑up) and to influence stem and progenitor cells, particularly in the immune system. However: The best data for dramatic immune cell “reset” effects come from mice, not humans. In humans, prolonged fasting clearly changes metabolic and inflammatory signaling, but fully regenerating tissues in a clinically meaningful way is not proven. Fasting for 72 hours is risky for many people, including those with diabetes, frailty, eating disorders, or certain medications. In my own practice, I treat fasting like a possible adjunct in select, well‑screened patients, never a standalone regenerative therapy. It is a lever on physiologic regeneration, not a magic reset button. 2. Reparative regeneration: healing after injury Reparative regeneration is what most people picture when they think of healing. There is an injury, and the body sets off a coordinated inflammatory and repair response. Classic examples include: A bone fracture that knits over weeks. A muscle strain that repairs and regains strength. Skin that re‑epithelializes after a cut or abrasion. The key nuance is that reparative regeneration does not always restore full original structure. For some tissues, the result is scar, not a true re‑creation of the original architecture. In orthopedics and sports medicine, a good portion of what regenerative medicine doctors do is aimed at nudging reparative regeneration toward a more complete, higher‑quality outcome. For instance: PRP injections: Concentrated platelets from a person’s own blood are injected into a tendon or joint to amplify growth factors at the injury site. This can stimulate more organized collagen deposition and better tendon structure, especially in early or moderate tendinopathy. Bone marrow concentrate or micro‑fragmented fat injections: These contain a mix of cells, signaling molecules, and scaffolding components. In carefully selected patients with early osteoarthritis or focal cartilage damage, they can help reduce pain and improve function, likely by calming inflammation and fostering higher‑quality reparative tissue. Biologic scaffolds: Some surgeons use extracellular matrix (ECM) products as patches or wraps to guide tissue repair, especially in complex rotator cuff tears or ligament reconstructions. Is regenerative medicine painful at this stage? Many procedures involve needles, and some, such as bone marrow aspiration for cell concentrate, can be moderately painful without good local anesthesia. In-office PRP injections tend to cause temporary pressure and soreness. Most patients describe the experience as uncomfortable but tolerable, more like a dental procedure than like surgery. 3. Compensatory regeneration: when the body leans on its backups Compensatory regeneration describes situations in which a tissue or organ cannot fully regrow the missing part, but the remaining structure enlarges or adapts to restore function. The classic example is the liver. A person can lose up to 60 to 70 percent of liver mass in a donation or surgical resection, and the remaining segment can grow to restore overall function. The newly grown liver is not a clone of the original anatomy, but functionally it can be close. Other examples: Kidney: If one kidney is removed, the remaining kidney often enlarges and increases its filtration capacity. Heart: Cardiac muscle does not regenerate well, so after a heart attack the surviving myocardium remodels and hypertrophies in a compensatory attempt to maintain output. Sometimes this adaptation eventually becomes maladaptive and leads to heart failure. Lung: After removal of part of a lung, the remaining lung tissue and chest cavity can remodel, increasing volume and function relative to the new baseline. In modern regenerative medicine, many therapies try to assist or refine compensatory regeneration rather than trigger full organ regrowth. For example: Biologic therapies after a heart attack aim to limit scarring, protect surviving cardiomyocytes, and improve vascular supply. Stem cell injections into the heart have shown modest benefits at best in large trials, and their mechanism seems more about paracrine signaling (releasing helpful molecules) than about truly creating new heart muscle. In osteoarthritis, the joint does not “grow a new surface,” but partial cartilage repair and improved synovial environment can allow surrounding muscle and ligaments to compensate, stabilizing the joint so pain and function improve even without perfect structural MRI changes. When patients ask, “What is the success rate of regenerative medicine?” for conditions like knee osteoarthritis, honest numbers vary: For carefully selected patients with mild to moderate osteoarthritis who receive well‑prepared PRP, response rates in published studies often land around 60 to 80 percent showing meaningful pain and function improvement at 6 to 12 months. For more advanced disease or poorly selected patients, success rates are lower, and results may be short‑lived. True cartilage regrowth that looks like native cartilage on imaging is uncommon. Functional improvement is more realistic than complete structural regeneration. A large part of clinical judgment in this field is deciding when you can lean on compensatory regeneration and when the disease is simply too advanced. 4. Induced or therapeutic regeneration: guided repair with medical tools Induced regeneration is where most of the public interest lies. This is what people imagine when they think of stem cells, gene therapy, or tissue engineering. Here, we are not just watching what the body does. We actively intervene to change the behavior of cells and tissues. Techniques range from relatively simple to highly experimental: Platelet‑based therapies, bone marrow and fat‑derived cell concentrates, and prolotherapy injections. Culture‑expanded stem cell treatments, typically in research settings and only occasionally allowed in clinical practice within strict regulations. Gene therapies that aim to correct or silence harmful mutations, some of which indirectly support regenerative capacity. Tissue engineering, where cells are grown on scaffolds outside the body, then implanted. This is also where a lot of the hype and confusion comes in. People often ask, “Where did Joe Rogan get his stem cell treatment?” His widely discussed treatment was in Panama, at a private clinic marketed as the Stem Cell Institute. Facilities there have used high‑dose intravenous mesenchymal stem cells, often derived from umbilical cord tissue. These protocols are largely outside standard US regulatory frameworks, and while some patients report improvements, rigorous controlled data are limited. That leads directly to another common question: “What country is best for stem cell treatment?” There is no single best country. Different places offer different balances of regulation, safety, and innovation: United States, Canada, Western Europe, Japan: Tighter regulation, slower approval of new methods, generally safer and more evidence‑based, but fewer “miracle cure” options. Panama, Mexico, parts of Eastern Europe and Asia: More permissive or less clear regulatory environments, more clinics offering high‑dose or exotic stem cell therapies, but more variable quality and less robust data. When patients are drawn to medical tourism, I urge them to look for three things: transparency about protocols, published data in peer‑reviewed journals, and clear follow‑up processes including complication management. What is a regenerative medicine doctor, really? A regenerative medicine doctor is not usually a separate specialty with its own residency. Instead, it is a focus area for physicians who come from existing fields: Orthopedics Physical medicine and rehabilitation (PM&R) Sports medicine Interventional pain medicine Dermatology and plastic surgery Cardiology or cardiovascular surgery Hematology and oncology Endocrinology and internal medicine in some cases So when someone asks, “How much do regenerative medicine doctors make?” the answer depends on the underlying specialty and practice model. A PM&R physician doing regenerative injections in a community clinic may earn in the range of 250,000 to 400,000 USD annually. An orthopedic surgeon or interventional pain physician running a high‑volume private practice with cash‑pay biologic procedures may earn significantly more, sometimes 500,000 to 1 million USD or beyond. That connects with the broader question, “Who is the highest paid doctor specialty?” In recent US compensation surveys, neurosurgeons and orthopedic surgeons typically top the list, often in the 700,000 to 1 million USD range in high‑earning situations. On the other end, “What is the lowest paying doctor specialty?” is usually answered by fields such as pediatrics, preventive medicine, or family medicine, which often sit in the 200,000 to 260,000 USD range, depending on region and practice type. Regenerative medicine is an overlay on top of these core specialties, not a salary category on its own. Who is a good candidate for regenerative medicine? The ideal candidate is not always the person who is suffering the most. Outcomes depend heavily on timing, tissue health, and expectations. Here is a pragmatic way to think about it: The underlying condition should be structural but not completely destroyed. Mild to moderate osteoarthritis, partial tendon tears, early degenerative disc changes, focal cartilage injuries, and certain ligament sprains often respond better than end‑stage bone‑on‑bone arthritis or complete tendon ruptures. The patient should be medically stable enough to heal. Poorly controlled diabetes, heavy smoking, severe obesity, systemic inflammatory diseases, and chronic steroid use can blunt regenerative capacity. The patient has already tried standard conservative care. Good physical therapy, activity modification, and core medical management set a solid foundation. Regenerative injections work best as an addition, not a shortcut around rehabilitation. Expectations should be realistic. Many patients achieve 30 to 70 percent symptom improvement and delay or avoid surgery for a time. Full restoration of a 60‑year‑old knee to a 20‑year‑old knee is not realistic. The provider is disciplined about patient selection. A doctor who says “this will cure anything” is usually selling something, not practicing medicine. That last point relates directly to the biggest problem with regenerative medicine as it stands today. The biggest problem and the main disadvantages The science behind regenerative mechanisms is strong and growing. The problem is the gap between that science and the way therapies are marketed and delivered. Several disadvantages and challenges recur in practice: First, evidence varies widely by condition and technique. Some applications, such as PRP for knee osteoarthritis or chronic lateral epicondylitis, have reasonably good randomized trial data. Others, like many off‑label stem cell protocols for neurodegenerative diseases, rely heavily on case series or anecdotes. Second, regulation is patchy. In some countries, loosely regulated clinics mix legitimate therapies with unproven ones. Patients cannot easily tell which is which. That blurs public understanding of what regenerative medicine can actually deliver. Third, cost and access are real barriers. The average cost of regenerative medicine procedures varies by country, region, and complexity, but in the United States many in‑office PRP injections run between 500 and 2,500 USD per treatment. Bone marrow or adipose‑derived cell procedures may range from 3,000 to 8,000 USD or more, depending on how many joints or regions are treated. Fourth, insurance coverage is limited. When people ask, “Will insurance pay for regenerative medicine?” the honest answer is, often not. Many insurers view PRP, stem cell injections, and similar interventions as investigational for most musculoskeletal indications. There are exceptions: Some policies cover PRP for specific conditions, such as certain tendinopathies, if strict criteria are met. Certain biologic products used in surgery or wound care may be covered because they have specific FDA approvals. Questions like “Does insurance cover Kinetix?” are hard to answer generically because “Kinetix” may refer to branded regenerative injections or devices whose coverage varies by insurer and region. Most of those branded orthobiologic injections are still considered elective and cash‑based in many markets. Fifth, outcomes are not guaranteed. When regenerative treatments do not help, patients can feel they paid heavily for hope. That does not necessarily mean the therapy is fraudulent. Even strong treatments in medicine have non‑responders. The key is transparent communication about the probability and magnitude of benefit. From a clinical standpoint, the main disadvantages of regenerative medicine are uncertainty, variability, and cost. Those downsides can be acceptable in specific contexts, but they must be discussed openly. Is regenerative medicine painful? Pain depends on the procedure. Simple PRP injections into soft tissue, done with good local anesthesia, usually involve brief discomfort during the numbing process and a few days of soreness afterward. Intra‑articular injections into a knee, hip, or shoulder can produce transient pressure and ache. Most patients tolerate this without sedation. Bone marrow aspiration from the pelvis, required for some cell concentrates, can be painful during the procedure if not thoroughly numbed. Experienced operators typically use local anesthesia and, in some settings, mild sedation. Spine or nerve‑adjacent injections carry not only pain but also risk, so they are done with image guidance and careful technique. Patients often describe these as more intimidating than inherently painful. From years of seeing people walk in and out of procedures, what matters most is preparation and aftercare: clear expectations, pre‑procedure analgesia, and a realistic post‑procedure activity plan. How doctors use the 4 types of regeneration in everyday practice Good regenerative medicine practices do not chase every new gadget. Instead, they line up treatments with the underlying biology. Here is how the four types of regeneration translate into clinical strategy: Physiologic regeneration informs the basics: sleep, nutrition, metabolic health, hormonal balance, and physical activity. For a middle‑aged patient with knee pain, addressing metabolic syndrome and sleep apnea often does as much for joint symptoms as any injection. Reparative regeneration guides timing. Intervening early in a tendon injury, when fibers are disorganized but not fully torn, allows PRP or other biologics to enhance repair. Waiting until a tendon is nearly avulsed leaves surgery as the main option. Compensatory regeneration shapes rehabilitation. After joint injections, a skilled physical therapist helps surrounding muscles and joints take over more of the workload, capitalizing on pain reduction to retrain movement patterns. Induced regeneration is reserved for specific situations. A well‑thought‑out PRP plan or a carefully indicated bone marrow concentrate injection can be valuable tools, particularly in younger or middle‑aged patients with localized damage who want to delay arthroplasty. When someone asks for “stem cells in the knee” but the radiographs show nearly complete joint space loss and large osteophytes, the honest answer is that biology has limits. At that stage, a joint replacement may be more predictable and, in the long run, more cost‑effective. What about success rates and long‑term outcomes? Patients rightly want numbers, even though medicine is rarely that simple. Across conditions, a few patterns emerge: Soft tissue tendons and ligaments often respond better than advanced weight‑bearing cartilage. Younger age, better metabolic health, and earlier disease correlate with higher success rates. Many treatments show the strongest benefit in the 3 to 12 month window. Some maintain benefit beyond 2 years, especially with good rehabilitation; others taper off. When colleagues ask, “What is the success rate of regenerative medicine?” in musculoskeletal practice, I usually answer in ranges and specific use cases: Chronic tennis elbow with well‑targeted PRP: a good majority, perhaps 70 to 90 percent, achieve meaningful relief based on multiple trials. Mild to moderate knee osteoarthritis with PRP: roughly 60 to 80 percent show clinically important improvement at 6 to 12 months, with some maintaining benefit beyond that. Advanced bone‑on‑bone arthritis: success rates fall sharply, and symptoms often return, which is why I rarely recommend high‑cost biologics in that scenario. A candid pre‑procedure discussion of those ranges is as important as the injection itself. Balancing hope, hype, and reality Regeneration is not a single technology. It is a spectrum of mechanisms the body already uses, which doctors can sometimes amplify or redirect. Understanding the four main types of regeneration helps patients and clinicians align expectations with biology. Physiologic regeneration reminds us that sleep, nutrition, and metabolic health are not “soft” interventions but central pillars. Reparative and compensatory regeneration show why timing matters and why early, thoughtful treatment can change the trajectory of joint and soft tissue disease. Induced regeneration, including PRP and stem cell‑based approaches, offers real promise in selected scenarios but comes with cost, regulatory, and evidence gaps. The most trustworthy regenerative medicine doctors I know are not the ones with the flashiest websites. They are the ones who are willing to say “no” when biology, imaging, and clinical context suggest that a procedure is unlikely to help. If you are considering regenerative treatment, ask your prospective physician three things: How does my condition fit into the types of regeneration you are trying to enhance? What are the realistic ranges of benefit and the alternatives? And how will we decide together whether the outcome justifies the cost and risk? Regenerative Medicine Doctor Scottsdale Integrated Spine, Pain and Wellness Those conversations, more than any single technology, are what make regenerative medicine genuinely regenerative rather than merely expensive hope.Integrated Spine, Pain and Wellness 7425 E Shea Blvd Suite 102, Scottsdale, AZ 85260 4806608823